Acute Bloody Diarrhea: A Medical Emergency for Patients of All Ages

Gastroenterology

Volumn 136, Issue 6, 2009, Pages 1887-1898

  Holtz, Lori R ^a   Neill, Marguerite A ^b   Tarr, Phillip I ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; FLUCYTOSINE; NARCOTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ANAMNESIS; ANTIBIOTIC THERAPY; ARTICLE; BLOODY DIARRHEA; CAMPYLOBACTER; CHEMOTHERAPY; CLINICAL FEATURE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; CRYSTALLOID; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; EMERGENCY MEDICINE; ESCHERICHIA COLI; GASTROINTESTINAL HEMORRHAGE; HUMAN; LABORATORY TEST; MEDICAL CARE; MEDICAL EXAMINATION; MICROBIOLOGY; PARASITE; PRIORITY JOURNAL; RADIOGRAPHY; SALMONELLA; SHIGELLA; VIRUS;

EID: 65449128791     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2009.02.059     Document Type: Article

References (93)

1. Murphy M.S. Management of bloody diarrhoea in children in primary care. BMJ 336 (2008) 1010-1015
2. Goldsmid J.M., and Leggat P.A. The returned traveller with diarrhoea. Aust Fam Physician 36 (2007) 322-327
3. Razzaq S. Hemolytic uremic syndrome: an emerging health risk. Am Fam Physician 74 (2006) 991-996
4. Karch H., Tarr P.I., and Bielaszewska M. Enterohaemorrhagic Escherichia coli in human medicine. Int J Med Microbiol 295 (2005) 405-418
5. Welinder-Olsson C., and Kaijser B. Enterohemorrhagic Escherichia coli (EHEC). Scand J Infect Dis 37 (2005) 405-416
6. O'Ryan M., Prado V., and Pickering L.K. A millennium update on pediatric diarrheal illness in the developing world. Semin Pediatr Infect Dis 16 (2005) 125-136
7. Wieland T. Travellers in medical practice. [in German]. Praxis (Bern 1994) 94 (2005) 233-237
8. Cleary T.G. The role of Shiga-toxin-producing Escherichia coli in hemorrhagic colitis and hemolytic uremic syndrome. Semin Pediatr Infect Dis 15 (2004) 260-265
9. Uhlen S., Toursel F., and Gottrand F. Treatment of acute diarrhea: prescription patterns by private practice pediatricians. [in French]. Arch Pediatr 11 (2004) 903-907
10. Lawson J.M. Update on Escherichia coli O157:H7. Curr Gastroenterol Rep 6 (2004) 297-301
11. Gore J.I., and Surawicz C. Severe acute diarrhea. Gastroenterol Clin North Am 32 (2003) 1249-1267
12. Pollock K.G., Stewart A., Beattie T.J., et al. From diarrhoea to haemolytic uraemic syndrome-when to seek advice. J Med Microbiol 58 (2009) 397-398
13. Chandler W.L., Jelacic S., Boster D.R., et al. Prothrombotic coagulation abnormalities preceding the hemolytic-uremic syndrome. N Engl J Med 346 (2002) 23-32
14. Tarr P.I., Gordon C.A., and Chandler W.L. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 365 (2005) 1073-1086
15. Tsai H.M., Chandler W.L., Sarode R., et al. von Willebrand factor and von Willebrand factor-cleaving metalloprotease activity in Escherichia coli O157:H7-associated hemolytic uremic syndrome. Pediatr Res 49 (2001) 653-659
16. Inward C.D., Howie A.J., Fitzpatrick M.M., Rafaat F., Milford D.V., and Taylor C.M. Renal histopathology in fatal cases of diarrhoea-associated haemolytic uraemic syndrome. British Association for Paediatric Nephrology. Pediatr Nephrol 11 (1997) 556-559
17. Richardson S.E., Karmali M.A., Becker L.E., and Smith C.R. The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections. Hum Pathol 19 (1988) 1102-1108
18. Riella M.C., George C.R., Hickman R.O., et al. Renal microangiopathy of the hemolytic-uremic syndrome in childhood. Nephron 17 (1976) 188-203
19. Habib R. Pathology of the hemolytic uremic syndrome. In: Kaplan B.S., Trompeter R.S., and Moake J.L. (Eds). Hemolytic uremic syndrome and thrombotic thrombocytopenic purpura (1992), Marcel Dekker, New York, NY 315-353
20. Jones T.F., McMillian M.B., Scallan E., et al. A population-based estimate of the substantial burden of diarrhoeal disease in the United States; FoodNet, 1996-2003. Epidemiol Infect 135 (2007) 293-301
21. Monto A.S., Koopman J.S., Longini I.M., and Isaacson R.E. The Tecumseh study, XII: enteric agents in the community, 1976-1981. J Infect Dis 148 (1983) 284-291
22. Fox J.P., Hall C.E., Cooney M.K., Luce R.E., and Kronmal R.A. The Seattle virus watch; II, objectives, study population and its observation, data processing and summary of illnesses. Am J Epidemiol 96 (1972) 270-285
23. Herikstad H., Yang S., Van Gilder T.J., et al. A population-based estimate of the burden of diarrhoeal illness in the United States: FoodNet, 1996-7. Epidemiol Infect 129 (2002) 9-17
24. Denno D.M., Keene W.E., Hutter C.M., et al. A tri-county comprehensive assessment of risk factors for sporadic bacterial reportable enteric infections in children. J Infect Dis 199 (2009) 467-476
25. Karama M., and Gyles C.L. Methods for genotyping verotoxin-producing Escherichia coli. Zoonoses Public Health 56 (2009) (in press)
26. Klein E.J., Stapp J.R., Clausen C.R., et al. Shiga toxin-producing Escherichia coli in children with diarrhea: a prospective point-of-care study. J Pediatr 141 (2002) 172-177
27. Wong C.S., Jelacic S., Habeeb R.L., Watkins S.L., and Tarr P.I. The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med 342 (2000) 1930-1936
28. Klein E.J., Boster D.R., Stapp J.R., et al. Diarrhea etiology in a Children's Hospital Emergency Department: a prospective cohort study. Clin Infect Dis 43 (2006) 807-813
29. Tarr P.I., Weinberger E., Hatch Jr. E.I., and Christie D.L. Bacterial ileocecitis caused by Escherichia coli O157:H7. J Pediatr Gastroenterol Nutr 14 (1992) 261-263
30. Puylaert J.B., Vermeijden R.J., van der Werf S.D., Doornbos L., and Koumans R.K. Incidence and sonographic diagnosis of bacterial ileocaecitis masquerading as appendicitis. Lancet 2 (1989) 84-86
31. Puylaert J.B., Van der Zant F.M., and Mutsaers J.A. Infectious ileocecitis caused by Yersinia, Campylobacter, and Salmonella: clinical, radiological and US findings. Eur Radiol 7 (1997) 3-9
32. Miller F.H., Ma J.J., and Scholz F.J. Imaging features of enterohemorrhagic Escherichia coli colitis. AJR Am J Roentgenol 177 (2001) 619-623
33. Klein E.J., Kapoor D., and Shugerman R.P. The diagnosis of intussusception. Clin Pediatr (Phila) 43 (2004) 343-347
34. Tarr P, Hecht G, Bass D. Bacterial, viral, and toxic causes of diarrhea, gastroenteritis, and anorectal infections. In: Yamada T, Alpers DH, Kaplowitz N, Kalloo A, Owyang C, Powell DW, eds. Textbook of gastroenterology. 5th ed. Oxford, United Kingdom: Blackwell Publishing (in press).
35. Bennett Jr. W.E., and Tarr P. Enteric infections and diagnostic testing. Curr Opin Gastroenterol 25 (2009) 1-7
36. Boyce T.G., Pemberton A.G., Wells J.G., and Griffin P.M. Screening for Escherichia coli O157:H7-a nationwide survey of clinical laboratories. J Clin Microbiol 33 (1995) 3275-3277
37. Voetsch A.C., Angulo F.J., Rabatsky-Ehr T., et al. Laboratory practices for stool-specimen culture for bacterial pathogens, including Escherichia coli O157:H7, in the FoodNet sites, 1995-2000. Clin Infect Dis 38 Suppl 3 (2004) S190-S197
38. Hennessy T.W., Marcus R., Deneen V., et al. Survey of physician diagnostic practices for patients with acute diarrhea: clinical and public health implications. Clin Infect Dis 38 Suppl 3 (2004) S203-S211
39. Centers for Disease Control and Prevention. Diagnosis of Shiga toxin-producing Escherichia coli by clinical diagnostic laboratories, STEC Clinical Diagnostics Working Group (in press).
40. Bartlett J.G., and Gerding D.N. Clinical recognition and diagnosis of Clostridium difficile infection. Clin Infect Dis 46 Suppl 1 (2008) S12-S18
41. Kelly C.P., and LaMont J.T. Clostridium difficile-more difficult than ever. N Engl J Med 359 (2008) 1932-1940
42. Planche T., Aghaizu A., Holliman R., et al. Diagnosis of Clostridium difficile infection by toxin detection kits: a systematic review. Lancet Infect Dis 8 (2008) 777-784
43. Ticehurst J.R., Aird D.Z., Dam L.M., Borek A.P., Hargrove J.T., and Carroll K.C. Effective detection of toxigenic Clostridium difficile by a two-step algorithm including tests for antigen and cytotoxin. J Clin Microbiol 44 (2006) 1145-1149
44. Reller M.E., Lema C.A., Perl T.M., et al. Yield of stool culture with isolate toxin testing versus a two-step algorithm including stool toxin testing for detection of toxigenic Clostridium difficile. J Clin Microbiol 45 (2007) 3601-3605
45. Huicho L., Campos M., Rivera J., and Guerrant R.L. Fecal screening tests in the approach to acute infectious diarrhea: a scientific overview. Pediatr Infect Dis J 15 (1996) 486-494
46. Puylaert J.B. Imaging and intervention in patients with acute right lower quadrant disease. Baillieres Clin Gastroenterol 9 (1995) 37-51
47. Morgan J., Bell M., and Sadler M.A. CT imaging of acute E. coli-related colitis. Emerg Radiol 14 (2007) 187-189
48. Hall E.J., and Brenner D.J. Cancer risks from diagnostic radiology. Br J Radiol 81 (2008) 362-378
49. Brenner D.J., and Hall E.J. Computed tomography-an increasing source of radiation exposure. N Engl J Med 357 (2007) 2277-2284
50. Sakellaris G., Tilemis S., and Charissis G. Acute appendicitis in preschool-age children. Eur J Pediatr 164 (2005) 80-83
51. Nussinovitch M., Shapiro R.P., Cohen A.H., and Varsano I. Shigellosis complicated by perforated appendix. Pediatr Infect Dis J 12 (1993) 352-353
52. Kravitz G.R., Smith K., and Wagstrom L. Colonic necrosis and perforation secondary to Escherichia coli O157:H7 gastroenteritis in an adult patient without hemolytic uremic syndrome. Clin Infect Dis 35 (2002) e103-e105
53. Helms M., Simonsen J., and Molbak K. Foodborne bacterial infection and hospitalization: a registry-based study. Clin Infect Dis 42 (2006) 498-506
54. Brown J.W. Toxic megacolon associated with loperamide therapy. JAMA 241 (1979) 501-502
55. Eronen M., Putkonen H., Hallikainen T., and Vartiainen H. Lethal gastroenteritis associated with clozapine and loperamide. Am J Psychiatry 160 (2003) 2242-2243
56. Smith G.S., and Blaser M.J. Fatalities associated with Campylobacter jejuni infections. JAMA 253 (1985) 2873-2875
57. Taylor D.N., Sanchez J.L., Candler W., Thornton S., McQueen C., and Echeverria P. Treatment of travelers' diarrhea: ciprofloxacin plus loperamide compared with ciprofloxacin alone. A placebo-controlled, randomized trial. Ann Intern Med 114 (1991) 731-734
58. Murphy G.S., Bodhidatta L., Echeverria P., et al. Ciprofloxacin and loperamide in the treatment of bacillary dysentery. Ann Intern Med 118 (1993) 582-586
59. Bell B.P., Griffin P.M., Lozano P., Christie D.L., Kobayashi J.M., and Tarr P.I. Predictors of hemolytic uremic syndrome in children during a large outbreak of Escherichia coli O157:H7 infections. Pediatrics 100 (1997) E12
60. Cimolai N., and Carter J.E. Bacterial genotype and neurological complications of Escherichia coli O157:H7-associated haemolytic uraemic syndrome. Acta Paediatr 87 (1998) 593-594
61. Cimolai N., Morrison B.J., and Carter J.E. Risk factors for the central nervous system manifestations of gastroenteritis-associated hemolytic-uremic syndrome. Pediatrics 90 (1992) 616-621
62. Wistrom J., Jertborn M., Ekwall E., et al. Empiric treatment of acute diarrheal disease with norfloxacin. A randomized, placebo-controlled study. Swedish Study Group. Ann Intern Med 117 (1992) 202-208
63. Goodman L.J., Trenholme G.M., Kaplan R.L., et al. Empiric antimicrobial therapy of domestically acquired acute diarrhea in urban adults. Arch Intern Med 150 (1990) 541-546
64. Dryden M.S., Gabb R.J., and Wright S.K. Empirical treatment of severe acute community-acquired gastroenteritis with ciprofloxacin. Clin Infect Dis 22 (1996) 1019-1025
65. Noguerado A., Garcia-Polo I., Isasia T., et al. Early single dose therapy with ofloxacin for empirical treatment of acute gastroenteritis: a randomised, placebo-controlled double-blind clinical trial. J Antimicrob Chemother 36 (1995) 665-672
66. Dundas S., Todd W.T., Stewart A.I., Murdoch P.S., Chaudhuri A.K., and Hutchinson S.J. The central Scotland Escherichia coli O157:H7 outbreak: risk factors for the hemolytic uremic syndrome and death among hospitalized patients. Clin Infect Dis 33 (2001) 923-931
67. Thielman N.M., and Guerrant R.L. Clinical practice. Acute infectious diarrhea. N Engl J Med 350 (2004) 38-47
68. Neill M.A., Opal S.M., Heelan J., et al. Failure of ciprofloxacin to eradicate convalescent fecal excretion after acute salmonellosis: experience during an outbreak in health care workers. Ann Intern Med 114 (1991) 195-199
69. Ake J.A., Jelacic S., Ciol M.A., et al. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion. Pediatrics 115 (2005) e673-e680
70. Werber D., Mason B.W., Evans M.R., and Salmon R.L. Preventing household transmission of Shiga toxin-producing Escherichia coli O157 infection: promptly separating siblings might be the key. Clin Infect Dis 46 (2008) 1189-1196
71. Siegel D., Cohen P.T., Neighbor M., et al. Predictive value of stool examination in acute diarrhea. Arch Pathol Lab Med 111 (1987) 715-718
72. Jacobs D.O. Clinical practice. Diverticulitis. N Engl J Med 357 (2007) 2057-2066
73. Loftus Jr. E.V. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 126 (2004) 1504-1517
74. Greenwald D.A., Brandt L.J., and Reinus J.F. Ischemic bowel disease in the elderly. Gastroenterol Clin North Am 30 (2001) 445-473
75. Hunt C.M., Harvey J.A., Youngs E.R., Irwin S.T., and Reid T.M. Clinical and pathological variability of infection by enterohaemorrhagic (Vero cytotoxin producing) Escherichia coli. J Clin Pathol 42 (1989) 847-852
76. McDonald L.C., Killgore G.E., Thompson A., et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 353 (2005) 2433-2441
77. Loo V.G., Poirier L., Miller M.A., et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 353 (2005) 2442-2449
78. Severe Clostridium difficile-associated disease in populations previously at low risk-four states, 2005. MMWR Morb Mortal Wkly Rep 54 (2005) 1201-1205
79. Surveillance for community-associated Clostridium difficile-Connecticut, 2006. MMWR Morb Mortal Wkly Rep 57 (2008) 34-343
80. Steffen R. Epidemiology of traveler's diarrhea. Clin Infect Dis 41 Suppl 8 (2005) S536-S540
81. Parry C.M., Hien T.T., Dougan G., White N.J., and Farrar J.J. Typhoid fever. N Engl J Med 347 (2002) 1770-1782
82. Haque R., Huston C.D., Hughes M., Houpt E., and Petri Jr. W.A. Amebiasis. N Engl J Med 348 (2003) 1565-1573
83. Elliott D.E. Schistosomiasis. Pathophysiology, diagnosis, and treatment. Gastroenterol Clin North Am 25 (1996) 599-625
84. Slutsker L., Ries A.A., Greene K.D., Wells J.G., Hutwagner L., and Griffin P.M. Escherichia coli O157:H7 diarrhea in the United States: clinical and epidemiologic features. Ann Intern Med 126 (1997) 505-513
85. Speights V.O., Johnson M.W., Stoltenberg P.H., Rappaport E.S., Helbert B., and Riggs M. Colorectal cancer: current trends in initial clinical manifestations. South Med J 84 (1991) 575-578
86. Steinberg S.M., Barkin J.S., Kaplan R.S., and Stablein D.M. Prognostic indicators of colon tumors. The Gastrointestinal Tumor Study Group experience. Cancer 57 (1986) 1866-1870
87. Stechman M., Safranek P., and Purkayastha S. Intussusception in a young adult with bloody diarrhoea. Int J Surg 2 (2004) 121-122
88. Babyatsky M.W., Keroack M.D., Blake M.A., Rosenberg E.S., and Mino-Kenudson M. Case records of the Massachusetts General Hospital. Case 35-2007. A 30-year-old man with inflammatory bowel disease and recent onset of fever and bloody diarrhea. N Engl J Med 357 (2007) 2068-2076
89. Levine W.C., Smart J.F., Archer D.L., Bean N.H., and Tauxe R.V. Foodborne disease outbreaks in nursing homes, 1975 through 1987. JAMA 266 (1991) 2105-2109
90. Brandt L.J. Bloody diarrhea in an elderly patient. Gastroenterology 128 (2005) 157-163
91. Surawicz C.M., and Belic L. Rectal biopsy helps to distinguish acute self-limited colitis from idiopathic inflammatory bowel disease. Gastroenterology 86 (1984) 104-113
92. Surawicz C.M. The role of rectal biopsy in infectious colitis. Am J Surg Pathol 12 Suppl 1 (1988) 82-88
93. Surawicz C.M., Haggitt R.C., Husseman M., and McFarland L.V. Mucosal biopsy diagnosis of colitis: acute self-limited colitis and idiopathic inflammatory bowel disease. Gastroenterology 107 (1994) 755-763